David A. Siegel Hutchmed (China) LTD Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 11,200 shares of HCM stock, worth $201,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,200Holding current value
$201,040% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HCM
# of Institutions
67Shares Held
8.29MCall Options Held
3.8KPut Options Held
2.4K-
Schroder Investment Management Group London, X03.02MShares$54.3 Million0.06% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.5MShares$27 Million0.04% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.15MShares$20.6 Million0.33% of portfolio
-
Acadian Asset Management LLC Boston, MA389KShares$6.98 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny358KShares$6.42 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $3.1B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...